The comparison of insulin levels between over weighted and non-obese smokers

KARAKOCA, Esat; YALCINB, Bektas Murat; YALCİNC, Esra

The comparison of insulin levels between over weighted and non-obese smokers

Esat KARAKOCA, (Department of Family Practice, Faculty of Medicine, Medicalpark Izmir Hospital, Izmir, Turkey b)

Bektas Murat YALCINB, (Department of Family Practice, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey)

Esra YALCİNC (Deartment of Neurology, Facult of Medicine, Gazi State Hospital, Samsun, Turkey)

Journal of Experimental and Clinical Medicine

0 0

Yıl: 2017 Cilt: 34 Sayı: 1 Sayfa Aralığı: 67 - 71 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

The comparison of insulin levels between over weighted and non-obese smokers

Öz:

Article HistoryReceived Accepted 14 / 10 / 201606 / 02 / 2017Cardiovasculer diseases are the most common reason for morbidity and mortality in the world. Smoking and obesity are among the most important avoidable reasons for these diseases. However, in Turkey, there are not enough studies about the effect of obesity (central and androgenic) on insulin levels of smokers. With this aim; oral glucose tolerance test (OGTT) was performed on 84 patients who meet the study criteria among 211 patients treated at the second internal diseases clinic of Taksim Hospital between November 1997 and May 1998, who were volunteers, smokers and older than 18. In addition, the total cholesterol, HDL, LDL and triglicerid levels of these patiens were checked. Heights, weights and waist circumferences of patients were measured. From these datas, body mass indexes (BMI) and waist circumferences (WC) were calculated. Nicotine addiction levels of patients were evaluated by Fagerstrom Nicotine Dependency Test (FNDT) and package/year amounts were calculated. According to the results based on the data obtained from the studies, no difference were determined (p>0.05), in ages, FNDT scores, insulin, TC, LDL and HDL levels between overweighted and normal weighted patients. On the other hand; there was statistically significant difference between two groups in BMI values, WC measurements (between different genders) and TG levels. In the regression analysis; BMI [OR: 1.512, (95% CI min=0.928, max=2.069)] and WC [OR: 1.912, (95% CI min=1.051, max=2.125)] was founded as a risk factor for the insulin increment. Additional information about the subject for the large participation cross-sectional studies. More action about life style modification (smoking cessation and an effective weight control) may increase risk of cardiovascular diseases in populations

Anahtar Kelime:

Konular: Tıbbi Araştırmalar Deneysel

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

Canoy, D., Wareham, N., Luben, R., 2005. Cigarette smoking and fat distribution in 21, 828 British men and women: A populationbased study. Obes. Res. 13, 1466-1475.
Carantoni, M., Abbas, F., Azhar, S., Schaaf, P., Reaven, G.M., 1999. References in insulin resistance: The link between obesity and cardiovascular disease. J. Clin. Endocrinol. Metab. 84, 869-872.
Chiolero, A., Faeh, D., Paccaud, F., Cornuz, J., 2008. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am. J. Clin. Nutr. 8, 87, 801-809.
Cibičková, Ľ., Karásek, D., Langová, K., Vaverková, H., Orság, J., Lukeš, J., Novotný, D., 2014. Correlation of lipid parameters and markers of insulin resistance: does smoking make a difference? Physiol. Res. 3, 387-393.
De Fronzo, R.A., Lnogmore, J.M., Hodgetts, T.J., Ramrakha, P.S., 1985. Oxford Handbook of Clinical Medicine. Thirteenth edition. Oxford Press. Oxford.
Fagerström, K.O., Kunze, M., Schoberberger, R., Breslau, N., Hughes, J.R., Hurt, R.D., Puska, P., Ramstrom, L., Zatonski, W., 1996. Nicotine dependence versus smoking prevalence: Comparisons among countries and categories of smokers. Tobacco Control. 5, 52-56.
Fidancı, İ., Tekin, O., Arslan, İ., Eren, Ş,Ü., Dinçer, G., Kızıltaş, Ö., 2015. The effect of smoking dependency on HbA1C. Ankara Med. J. 15, 127-133.
Fox C.S., Evans J.C., Larson M.G., Kannel, W.B., Levy, D., 2004. Temporal trend in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: The Framingham Study. Circulation. 110, 522-527.
Harris, K.K., Zopey, M,. Friedman, TC., 2016. Nat. Rev. Endocrinol, 12, 299-308
Hinnouho, G., Czernichow, S., Dugravot, A., Batty, G.D., Kivimaki, M., Singh-Manoux, A., 2013. Metabolically healthy obesity and risk of mortality: Does the defnition of metabolic health matter? Diabetes Care. Epub ahead of print. 2.
Istvan, J., Cunningham, T., Garfnkel, L., 1992. Cigarette smoking and body weight in the cancer prevention study I. Int. J. Epidemiol. 21, 849-853.
Li, L., Yin, X., Yu, D., Li, H., 2016. Impact of physical activity on glycemic control and insulin resistance: A study of communitydwelling diabetic patients in eastern China. Intern. Med. 55, 1055-1060.
Lwite, M.L., Nicolasi, A., 2006. Lifestyle correlates of anthpometric estimates of body adiposity in an Italian middle-aged and elderly population: A covariance analysis. Int. J. Obes. 30, 926-934.
Mandeep, B., 2012. Nicotine and insulin resistance: When the Smoke Clears. Diabates. 61, 3079-3080.
Morimoto, A., Tatsumi, Y., Deura, K., Mizuno, S., Ohno, Y., Watanabe, S., 2013. Impact of cigarette smoking on impaired insulin secretion and insulin resistance in Japanese men: The Saku Study. J. Diabetes Investig. 4, 274-280.
NIH (National Institute of Health), 2002, Third Report of National Cholesterol Education Program (NCEP) Expert Panel. Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). NIH publication No.02-5215. 2002. http://www.nhlbi.nih.gov.resources.ATPIII.pdf.
Schroeder, S., 2013. Smoking-related mortality in the United States. N. Engl. J. Med. 368, 1753-1754.
Şenyüz, L., Coştur, R., 2010. The assessment of smoker and non-smoker university students of the warning words on the cigarette packages. J. Faculty Lett. 27, 253-270.
Szulinska, M., Piorunek, T., Suliburska, J., Pupek-Musialik, D., Kupsz, J., Drzymala-Czyz, S., Bogdanski, P., 2013. Evaluation of insulin resistance, tumor necrosis factor alpha, and total antioxidant status in obese patients smoking cigarettes. Eur. Rew. Med. Pharmacol. Sci.17,1916-1922.
Wild, S.H., Byrne, C.D., 2006. ABC of obesity. Risk factors for diabetes and coronary heart disease. BMJ. 333, 1009-1011.
Williamson, D.F., Madans, J., Anda, R.F., Kleinman, J.C.,Giovino, G.A., Byers,T., 1991. Smoking cessation and severity of weight gain in a national cohort. N. Engl. Med. 324, 739-745.

APA	KARAKOCA E, YALCINB B, YALCİNC E (2017). The comparison of insulin levels between over weighted and non-obese smokers. , 67 - 71.
Chicago	KARAKOCA Esat,YALCINB Bektas Murat,YALCİNC Esra The comparison of insulin levels between over weighted and non-obese smokers. (2017): 67 - 71.
MLA	KARAKOCA Esat,YALCINB Bektas Murat,YALCİNC Esra The comparison of insulin levels between over weighted and non-obese smokers. , 2017, ss.67 - 71.
AMA	KARAKOCA E,YALCINB B,YALCİNC E The comparison of insulin levels between over weighted and non-obese smokers. . 2017; 67 - 71.
Vancouver	KARAKOCA E,YALCINB B,YALCİNC E The comparison of insulin levels between over weighted and non-obese smokers. . 2017; 67 - 71.
IEEE	KARAKOCA E,YALCINB B,YALCİNC E "The comparison of insulin levels between over weighted and non-obese smokers." , ss.67 - 71, 2017.
ISNAD	KARAKOCA, Esat vd. "The comparison of insulin levels between over weighted and non-obese smokers". (2017), 67-71.

APA	KARAKOCA E, YALCINB B, YALCİNC E (2017). The comparison of insulin levels between over weighted and non-obese smokers. Journal of Experimental and Clinical Medicine, 34(1), 67 - 71.
Chicago	KARAKOCA Esat,YALCINB Bektas Murat,YALCİNC Esra The comparison of insulin levels between over weighted and non-obese smokers. Journal of Experimental and Clinical Medicine 34, no.1 (2017): 67 - 71.
MLA	KARAKOCA Esat,YALCINB Bektas Murat,YALCİNC Esra The comparison of insulin levels between over weighted and non-obese smokers. Journal of Experimental and Clinical Medicine, vol.34, no.1, 2017, ss.67 - 71.
AMA	KARAKOCA E,YALCINB B,YALCİNC E The comparison of insulin levels between over weighted and non-obese smokers. Journal of Experimental and Clinical Medicine. 2017; 34(1): 67 - 71.
Vancouver	KARAKOCA E,YALCINB B,YALCİNC E The comparison of insulin levels between over weighted and non-obese smokers. Journal of Experimental and Clinical Medicine. 2017; 34(1): 67 - 71.
IEEE	KARAKOCA E,YALCINB B,YALCİNC E "The comparison of insulin levels between over weighted and non-obese smokers." Journal of Experimental and Clinical Medicine, 34, ss.67 - 71, 2017.
ISNAD	KARAKOCA, Esat vd. "The comparison of insulin levels between over weighted and non-obese smokers". Journal of Experimental and Clinical Medicine 34/1 (2017), 67-71.